...
机译:E3泛素连接酶CBL-B和C-CBL在EGFR EGFR EGFR野生型非小细胞肺癌中下调PD PD PD -L1
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Department of Medical Oncologythe First Hospital of China Medical UniversityShenyang China;
Cbl‐b; c‐Cbl; EGFR; lung cancer; PD ‐L1;
机译:E3泛素连接酶CBL-B和C-CBL在EGFR EGFR EGFR野生型非小细胞肺癌中下调PD PD PD -L1
机译:MA21.02鉴定e2泛素缀合物CDC34,与E3连接酶C-CBL竞争以稳定EGFR并促进肺癌发生
机译:泛素连接酶CBL-B涉及icotinib(BPI-2009h) - 诱导凋亡和GL期阻滞EGFR突变阳性非小细胞肺癌
机译:E3泛素连接酶CBL-B通过抑制PI3K / AKT信号通路和P-糖蛋白下调逆转MCF-7 / ADR细胞的多药耐药性
机译:Cbl和Cbl-b泛素天冬氨酸在乳腺发育和乳腺干细胞稳态中的作用。
机译:泛素连接酶Cbl-b参与Icotinib(BPI-2009H)诱导的EGFR突变阳性非小细胞肺癌细胞凋亡和G1期阻滞。
机译:E3泛素连接酶CBL-B和C-CBL在EGFR野生型非小细胞肺癌中下调PD -L1